Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...
There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to ...
Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.
Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and improve drug development by optimizing patient recruitment for clinical ...
Despite rebukes by two federal circuit courts, an HHS sub-agency continues to overstep its authority when administering a ...
The drugmaker has won an appeal against NICE's recent final draft guidance on Sarclisa (isatuximab) as a regimen alongside ...
Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...
The Punch Newspapers on MSN1h
Experts decry diabetes drugs cost as patients reach 14mMedical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...
After he stopped responding to several different therapies aimed at prolonging his life, doctors advised him to try a drug ...
New Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, ...
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback